NCT05131607View on ClinicalTrials.gov

21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 17, 2022

Primary Completion Date

July 3, 2023

Study Completion Date

March 31, 2024

Conditions
Breast Cancer Female
Interventions
PROCEDURE

Supine MRI

After completion of the standard prone MRI sequences the patient will be positioned supine, coils will be placed and baseline images will be obtained. Then a second dose of contrast equal to the first dose will be given, and additional images will be obtained

Trial Locations (1)

05055

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

CairnSurgical, Inc.
All Listed Sponsors
collaborator

CairnSurgical, Inc.

INDUSTRY

lead

Dartmouth-Hitchcock Medical Center

OTHER